Cargando…

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup

In neuroblastoma, MYCN amplification and 11q-deletion are important, although incomplete, markers of high-risk disease. It is therefore relevant to characterize additional alterations that can function as prognostic and/or predictive markers. Using SNP-microarrays, a group of neuroblastoma patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Monleon, Angela, Kryh Öberg, Hanna, Gaarder, Jennie, Berbegall, Ana P., Javanmardi, Niloufar, Djos, Anna, Ussowicz, Marek, Taschner-Mandl, Sabine, Ambros, Inge M., Øra, Ingrid, Sandstedt, Bengt, Beiske, Klaus, Ladenstein, Ruth, Noguera, Rosa, Ambros, Peter F., Gordon Murkes, Lena, Ljungman, Gustaf, Kogner, Per, Fransson, Susanne, Martinsson, Tommy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300649/ https://www.ncbi.nlm.nih.gov/pubmed/35859155 http://dx.doi.org/10.1038/s41598-022-16455-1

Ejemplares similares

Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma
por: Martinez-Monleon, Angela, et al.
Publicado: (2023)

Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment
por: Javanmardi, Niloufar, et al.
Publicado: (2019)

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation
por: Djos, Anna, et al.
Publicado: (2022)

Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene
por: Djos, Anna, et al.
Publicado: (2013)

Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance
por: Fransson, Susanne, et al.
Publicado: (2020)

The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2016)

Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging
por: Lazic, Daria, et al.
Publicado: (2021)

An annotated fluorescence image dataset for training nuclear segmentation methods
por: Kromp, Florian, et al.
Publicado: (2020)

Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression
por: Rifatbegovic, Fikret, et al.
Publicado: (2017)

Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence
por: Taschner-Mandl, Sabine, et al.
Publicado: (2015)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
por: Villamón, Eva, et al.
Publicado: (2013)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
por: Treis, Diana, et al.
Publicado: (2022)

Bone marrows from neuroblastoma patients: An excellent source for tumor genome analyses
por: Abbasi, M. Reza, et al.
Publicado: (2014)

Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma
por: Schriegel, Felix, et al.
Publicado: (2021)

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
por: Kryh, Hanna, et al.
Publicado: (2011)

Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours
por: Carén, H, et al.
Publicado: (2007)

Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas
por: Fransson, Susanne, et al.
Publicado: (2013)

Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies—A Validation Study
por: Rifatbegovic, Fikret, et al.
Publicado: (2015)

Human repair‐related Schwann cells adopt functions of antigen‐presenting cells in vitro
por: Berner, Jakob, et al.
Publicado: (2022)

Tumor Touch Imprints as Source for Whole Genome Analysis of Neuroblastoma Tumors
por: Brunner, Clemens, et al.
Publicado: (2016)

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
por: Carén, Helena, et al.
Publicado: (2011)

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
por: Defferrari, R, et al.
Publicado: (2015)

A genome-wide scan to locate regions associated with familial vesicoureteral reflux
por: Bartik, Zsuzsa, et al.
Publicado: (2022)

Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8
por: Weiss, Tamara, et al.
Publicado: (2021)

VP2: Schwann Cells Regulate Neuronal Differentiation by Epidermal Growth Factor-Like Protein 8
por: Weiss, Tamara, et al.
Publicado: (2022)

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
por: Ambros, Inge M., et al.
Publicado: (2020)

Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
por: Rasmuson, Agnes, et al.
Publicado: (2012)

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration()
por: Berbegall, Ana P., et al.
Publicado: (2014)

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
por: Bellini, Angela, et al.
Publicado: (2021)

TC-hunter: identification of the insertion site of a transgenic gene within the host genome
por: Börjesson, Vanja, et al.
Publicado: (2022)

Cine y educación : el cine en el aula de primaria y secundaria /
por: Ambròs, Alba
Publicado: (2007)

Mathematics of microRNAs: stabilizing gene regulatory networks
por: Ambros, Victor
Publicado: (2019)

Impulsschaltungen, Erzeugung und Verarbeitung von Impulsen mit Röhren und Transistoren
por: Speiser, Ambros P
Publicado: (1963)

Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics
por: Ambros, Inge M., et al.
Publicado: (2014)

Neurocognition and mean radiotherapy dose to vulnerable brain structures: new organs at risk?
por: Söderström, Helena, et al.
Publicado: (2023)

Análisis económico de la población y su relación con la crisis agrícola, en el Municipio de Landero y Coss, Veracruz
por: Ambros Escribano, Elda María
Publicado: (2012)

Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
por: Ambros-Rudolph, Christina M.
Publicado: (2011)

A cohort of Caenorhabditis species lacking the highly conserved let-7 microRNA
por: Nelson, Charles, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fgvmsleer29c91ao5oquvv58u